SCHEMBL9904113

SCHEMBL9904113

COc1ccccc1-c1cn(-c2nc3c([nH]2)c(=O)n(C)c(=O)n3C)nn1

nearest known ligand 0.63

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 4/20 0.49
ALDH1A1 P00352 2/20 0.49
HPGD P15428 2/20 0.49
HSD17B10 Q99714 2/20 0.49
USP2 O75604 1/20 0.49
PDE5A O76074 1/20 0.48
CYP1A2 P05177 2/20 0.47
CYP3A4 P08684 1/20 0.47
TDP1 Q9NUW8 1/20 0.46
ADORA2B P29275 3/20 0.44
ADORA3 P0DMS8 1/20 0.44
ADORA2A P29274 1/20 0.44
ADORA1 P30542 1/20 0.44
BLM P54132 1/20 0.44
NPSR1 Q6W5P4 1/20 0.44
DCTPP1 Q9H773 2/20 0.44
GAA P10253 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9928559 0.87 KDM4E (0.49) KDM4EALDH1A1HPGDHSD17B10USP2
SCHEMBL9904115 0.83 KDM4E (0.47) KDM4EALDH1A1HPGDHSD17B10USP2
SCHEMBL9928556 0.81 ADORA2B (0.61) KDM4EALDH1A1CYP1A2CYP3A4ADORA2B
SCHEMBL9928563 0.80 GAA (0.56) KDM4EALDH1A1HPGDHSD17B10CYP1A2
SCHEMBL9928557 0.80 ADORA2B (0.49) KDM4EHSD17B10CYP1A2CYP3A4ADORA2B
SCHEMBL9905475 0.80 KDM4E (0.52) KDM4EALDH1A1HPGDHSD17B10USP2
SCHEMBL9904126 0.79 DCTPP1 (0.56) KDM4EALDH1A1HPGDHSD17B10CYP1A2
SCHEMBL10712628 0.78 KDM4E (0.76) KDM4EALDH1A1HPGDHSD17B10USP2
SCHEMBL9943454 0.77 ALDH1A1 (0.64) KDM4EALDH1A1HSD17B10CYP1A2ADORA2B
SCHEMBL9904312 0.76 ADORA2B (0.48) KDM4EALDH1A1HSD17B10CYP1A2ADORA2B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2465859-A1 8-Triazolylxanthine derivatives, processes for their production and their use as adenosine receptor antagonists Life & Brain GmbH (DE) 2012-06-20 EP disclosed
EP-2465859-A1 8-Triazolylxanthine derivatives, processes for their production and their use as adenosine receptor antagonists Life & Brain GmbH (DE) 2012-06-20 EP disclosed
WO-2012076974-A1 8-TRIAZOLYLXANTHINE DERIVATIVES, PROCESSES FOR THEIR PRODUCTION AND THEIR USE AS ADENOSINE RECEPTOR ANTAGONISTS LIFE & BRAIN GMBH (DE) 2012-06-14 WO disclosed
WO-2012076974-A1 8-TRIAZOLYLXANTHINE DERIVATIVES, PROCESSES FOR THEIR PRODUCTION AND THEIR USE AS ADENOSINE RECEPTOR ANTAGONISTS LIFE & BRAIN GMBH (DE) 2012-06-14 WO disclosed